```html

Yong‑yang Fever (Mediterranean Spotted Fever)

Overview

Yong‑yang fever, also known as Mediterranean spotted fever (MSF) or “Boutonneuse fever,” is an acute febrile illness caused by the intracellular bacterium Rickettsia aeschlimannii or, more classically, Rickettsia conorii. The disease is transmitted to humans through the bite of infected ticks, primarily the brown dog tick (Rhipicephalus sanguineus).

MSF is most common in the Mediterranean basin, including southern Europe (Spain, Italy, Greece, Portugal), North Africa, the Middle East, and parts of Central Asia. In recent decades, travel and climate‑related expansion of tick habitats have led to isolated outbreaks in other regions such as Central Europe and even parts of the United States.

According to the World Health Organization (WHO), an estimated 5,000–8,000 cases are reported annually in endemic Mediterranean countries, with higher incidence during the warm months (May‑October) when tick activity peaks.

The disease can affect anyone bitten by an infected tick, but the highest risk groups are:

• Outdoor workers (farmers, shepherds, veterinarians)
• Military personnel stationed in endemic zones
• People who keep dogs that roam outdoors
• Travelers visiting rural or peri‑urban areas of the Mediterranean

Symptoms

Symptoms typically appear 5–7 days after the tick bite (incubation period 2–14 days). The clinical picture can be mild to severe, and not all patients develop every sign.

Early systemic signs (days 1‑3)

• Fever – sudden onset, often >38.5 °C (101.3 °F)
• Headache – usually frontal and throbbing
• Myalgia – muscle aches, especially in the calves and lower back
• General malaise – fatigue, feeling “ill”
• Gastro‑intestinal complaints – nausea, loss of appetite, occasional diarrhea

Specific dermatologic findings (days 2‑5)

• Eschar (tache noire) – a dark, crusted ulcer at the tick bite site; often 0.5‑2 cm in diameter and surrounded by a reddened halo.
• Maculopapular rash – appears 2‑5 days after fever, typically beginning on the trunk and spreading to the limbs. The rash may become petechial or vesicular in severe cases.
• Palmar/plantar involvement – rash may involve palms and soles, a clue that distinguishes MSF from many other febrile rashes.

Late or severe manifestations (after day 5)

• High‑grade fever persisting >7 days
• Confusion or altered mental status (rare, indicates CNS involvement)
• Hepatomegaly or mild hepatitis (elevated transaminases)
• Renal impairment (elevated creatinine, oliguria)
• Severe thrombocytopenia (<150 × 10⁹/L)
• Peripheral edema or hypotension – signs of systemic vasculitis

Causes and Risk Factors

Microbial cause

MSF is caused by Rickettsia conorii (the classic agent) or related species such as R. aeschlimannii. These bacteria are obligate intracellular Gram‑negative organisms that replicate in the cytoplasm of endothelial cells, leading to vasculitis and the characteristic rash.

Vector

The primary vector is the brown dog tick (Rhipicephalus sanguineus). The tick can acquire the bacteria from infected mammals (dogs, rodents, wild carnivores) and maintain it transstadially (through life stages). Humans are accidental hosts.

Risk factors

• Living in or traveling to endemic regions during the tick‑active season (May‑Oct).
• Close contact with stray or outdoor dogs that are infested with ticks.
• Occupations with frequent outdoor exposure (agriculture, forestry, animal husbandry).
• Not using personal protective measures (ticks repellents, protective clothing).
• Immunocompromised status (e.g., HIV, transplant recipients) may increase severity.

Diagnosis

Prompt diagnosis is essential because early antibiotic therapy dramatically reduces morbidity. Diagnosis relies on a combination of clinical suspicion, epidemiologic exposure, and laboratory testing.

Clinical assessment

• History of travel or residence in an endemic area.
• Recognition of the triad: fever, eschar, and maculopapular rash.
• Examination for tick bite sites and eschar.

Laboratory tests

• Complete blood count (CBC) – may reveal leukocytosis, thrombocytopenia.
• Liver function tests – mild transaminase elevation in 30‑40 % of cases.
• Serology – indirect immunofluorescence assay (IFA) for IgM/IgG antibodies to Rickettsia. A fourfold rise in titer between acute and convalescent sera (2‑3 weeks apart) confirms infection.
• Polymerase chain reaction (PCR) – detection of rickettsial DNA from blood, skin biopsy of eschar, or swab of the lesion. PCR offers rapid confirmation (24‑48 h) and is the preferred test when available.
• Immunohistochemistry of skin biopsy – shows organisms within endothelial cells; used in research settings.

Differential diagnosis

Conditions that can mimic MSF include:

• Other spotted fevers (e.g., African tick‑bite fever)
• Scrub typhus
• Rocky Mountain spotted fever (in travelers)
• Leptospirosis
• Viral exanthems (measles, rubella)

Treatment Options

First‑line antibiotic

The cornerstone of therapy is a tetracycline class drug:

• Doxycycline 100 mg orally twice daily for 7–10 days is recommended for adults and children of any age (including those <8 years). CDC notes doxycycline is safe in children for rickettsial infections.

Alternative agents

• Chloramphenicol 50 mg/kg/day IV divided q6h for 7–10 days – reserved for patients who cannot tolerate doxycycline (e.g., severe allergy) but carries risk of aplastic anemia.
• Azithromycin 500 mg PO once daily for 5 days – a reasonable option for pregnant women or those with doxycycline contraindication, though evidence is less robust.

Corticosteroids

Not routinely indicated. May be considered for severe vasculitic complications (e.g., CNS involvement) after infectious control is established.

Supportive care

• Fever control with acetaminophen (avoid NSAIDs if renal impairment).
• Intravenous fluids for dehydration or hypotension.
• Monitoring of liver and renal function in severe cases.

Hospitalization criteria

Patients with any of the following should be admitted:

• Signs of severe disease (high fever >40 °C, confusion, seizures).
• Pregnant women.
• Immunocompromised individuals.
• Platelet count <50 × 10⁹/L or rising creatinine.

Living with Yong‑yang fever (Mediterranean spotted fever)

Most individuals recover fully within 2–3 weeks after appropriate therapy. However, a few may experience lingering symptoms or need ongoing monitoring.

Post‑treatment follow‑up

• Schedule a follow‑up visit 10–14 days after completing antibiotics to ensure resolution of rash and fever.
• Repeat CBC and liver function tests if they were abnormal at presentation.
• Patients with persistent fatigue or joint pain should be evaluated for post‑infectious sequelae.

Managing residual symptoms

• Hydration and balanced nutrition to aid recovery.
• Gradual return to physical activity; avoid strenuous exercise for 2 weeks if fever persisted.
• Use over‑the‑counter analgesics (acetaminophen) for lingering aches.
• Consider physical therapy for joint stiffness.

Psychological wellbeing

Experiencing a febrile illness abroad can be stressful. Encourage patients to discuss anxieties with a primary‑care provider or a mental‑health professional if needed.

Prevention

Since MSF is tick‑borne, prevention targets tick exposure.

Personal protective measures

• Wear long‑sleeved shirts, long pants, and tuck pants into socks when in grassy or wooded areas.
• Apply EPA‑approved tick repellents containing 20‑30 % DEET, picaridin, or IR3535 to skin; treat clothing with permethrin (0.5 %).
• Perform thorough tick checks on yourself, children, and pets at the end of each day. Promptly remove attached ticks with fine‑tipped tweezers.
• Avoid walking through high‑grass or brush where ticks are active.

Environmental control

• Keep yards mowed and clear of leaf litter.
• Use acaricides on perimeters of yards and kennels where appropriate.
• Regularly treat domestic dogs with vet‑approved tick preventives (spot‑on, collars, oral meds).

Travel recommendations

• Consult a travel clinic 4–6 weeks before departure to an endemic area.
• Carry a small tick‑removal kit and know how to use it.
• If you develop fever within 2 weeks of returning from an endemic region, seek medical attention and mention possible tick exposure.

Complications

When untreated or delayed in treatment, MSF may progress to serious complications, occurring in 5‑10 % of cases:

• Severe vasculitis leading to skin necrosis or gangrene.
• Renal failure (acute tubular necrosis).
• Hepatitis (bilirubin >2 mg/dL).
• Neurologic involvement – encephalitis, seizures, or focal deficits.
• Cardiac manifestations – myocarditis, pericardial effusion.
• Respiratory distress – acute respiratory distress syndrome (ARDS) in rare cases.
• Secondary infections at the eschar site.

Mortality is low (<1 %) in immunocompetent patients receiving timely doxycycline, but it rises to 5‑10 % in the elderly or immunocompromised.

When to Seek Emergency Care

---

Sources: Mayo Clinic, CDC, WHO, National Institutes of Health (NIH), Cleveland Clinic, European Centre for Disease Prevention and Control (ECDC), peer‑reviewed articles in Clinical Infectious Diseases and The Lancet Infectious Diseases.

```